Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Ischemic Heart Disease

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 350 articles:
HTML format



Single Articles


    May 2022

  1. Correction to: Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity.
    Circulation. 2022 May 20:101161CIR0000000000001080.
    PubMed    


  2. PETEK BJ, Moulson N, Drezner JA, Harmon KG, et al
    Cardiovascular Outcomes in Collegiate Athletes Following SARS-CoV-2 Infection: 1-year Follow-up from the Outcomes Registry for Cardiac Conditions in Athletes.
    Circulation. 2022 May 12. doi: 10.1161/CIRCULATIONAHA.121.058272.
    PubMed    


  3. CHOW CK, Klimis H, Thiagalingam A, Redfern J, et al
    Text Messages to Improve Medication Adherence and Secondary Prevention After Acute Coronary Syndrome: The TEXTMEDS Randomized Clinical Trial.
    Circulation. 2022;145:1443-1455.
    PubMed     Abstract available


  4. NAGAREDDY PR, Sreejit G
    Response by Nagareddy and Sreejit to Letter Regarding Article, "Retention of the NLRP3 Inflammasome-Primed Neutrophils in the Bone Marrow Is Essential for Myocardial Infarction-Induced Granulopoiesis".
    Circulation. 2022;145:e1035-e1036.
    PubMed    


  5. REN C, Yang Z
    Letter by Ren and Yang Regarding Article, "Retention of the NLRP3 Inflammasome-Primed Neutrophils in the Bone Marrow Is Essential for Myocardial Infarction-Induced Granulopoiesis".
    Circulation. 2022;145:e1034.
    PubMed    


  6. WENGER NK, Lloyd-Jones DM, Elkind MSV, Fonarow GC, et al
    Call to Action for Cardiovascular Disease in Women: Epidemiology, Awareness, Access, and Delivery of Equitable Health Care: A Presidential Advisory From the American Heart Association.
    Circulation. 2022 May 9:101161CIR0000000000001071.
    PubMed     Abstract available


  7. BERLOWITZ JB, Xie W, Harlow AF, Hamburg NM, et al
    E-cigarette Use and Risk of Cardiovascular Disease: A Longitudinal Analysis of the PATH Study, 2013-2019.
    Circulation. 2022 May 6. doi: 10.1161/CIRCULATIONAHA.121.057369.
    PubMed    


  8. EMOTO T, Yamamoto H, Yamashita T, Takaya T, et al
    Single-Cell RNA Sequencing Reveals a Distinct Immune Landscape of Myeloid Cells in Coronary Culprit Plaques Causing Acute Coronary Syndrome.
    Circulation. 2022;145:1434-1436.
    PubMed    


    April 2022
  9. PATEL KK
    Improving Symptoms and Quality of Life in Stable Coronary Artery Disease: An Evolving Paradigm.
    Circulation. 2022;145:1308-1311.
    PubMed    


  10. BOUCHARD K, Liu PP, Tulloch H
    The Social Robots Are Coming: Preparing for a New Wave of Virtual Care in Cardiovascular Medicine.
    Circulation. 2022;145:1291-1293.
    PubMed    


  11. CHEN R, Jiang Y, Hu J, Chen H, et al
    Hourly Air Pollutants and Acute Coronary Syndrome Onset In 1.29 Million Patients.
    Circulation. 2022 Apr 22. doi: 10.1161/CIRCULATIONAHA.121.057179.
    PubMed     Abstract available



  12. Correction to: Coronary Artery and Cardiac Disease in Patients With Type 2 Myocardial Infarction: A Prospective Cohort Study.
    Circulation. 2022;145:e841.
    PubMed    


  13. LUSEBRINK E, Kellnar A, Krieg K, Binzenhofer L, et al
    Percutaneous Transvalvular Microaxial Flow Pump Support in Cardiology.
    Circulation. 2022;145:1254-1284.
    PubMed     Abstract available


  14. WHITE HD
    Zooming in on the Enigmas of Type 2 Myocardial Infarction.
    Circulation. 2022;145:1201-1204.
    PubMed    


  15. JIA D, Chen S, Bai P, Luo C, et al
    Cardiac Resident Macrophage-derived Legumain Improves Cardiac Repair via Promoting Clearance and Degradation of Apoptotic Cardiomyocytes after Myocardial Infarction.
    Circulation. 2022 Apr 18. doi: 10.1161/CIRCULATIONAHA.121.057549.
    PubMed     Abstract available


  16. VASAN RS, Enserro DM, Xanthakis V, Beiser AS, et al
    Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study.
    Circulation. 2022 Apr 18. doi: 10.1161/CIRCULATIONAHA.121.057889.
    PubMed     Abstract available


  17. ZHANG J, Liang R, Wang K, Zhang W, et al
    Novel CaMKII-delta Inhibitor Hesperadin Exerts Dual Functions to Ameliorate Cardiac Ischemia/Reperfusion Injury and Inhibit Tumor Growth.
    Circulation. 2022;145:1154-1168.
    PubMed     Abstract available


  18. JONE PN, John A, Oster ME, Allen K, et al
    SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults: A Scientific Statement From the American Heart Association.
    Circulation. 2022 Apr 11:101161CIR0000000000001064.
    PubMed     Abstract available


    March 2022
  19. SINGH T, Khan H, Gamble DT, Scally C, et al
    Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications.
    Circulation. 2022;145:1002-1019.
    PubMed     Abstract available


  20. KUEHN BM
    Higher Risk of Heart Disease Among South Asians Calls for Targeted Interventions.
    Circulation. 2022;145:1020-1021.
    PubMed    


  21. BULARGA A, Hung J, Daghem M, Stewart S, et al
    Coronary Artery and Cardiac Disease in Patients With Type 2 Myocardial Infarction: A Prospective Cohort Study.
    Circulation. 2022 Mar 28. doi: 10.1161/CIRCULATIONAHA.121.058542.
    PubMed    



  22. Correction to: Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2022;145:e775.
    PubMed    


  23. NG CF, Teoh JYC, Chiu PKF
    Letter by Ng et al Regarding Article, "Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial".
    Circulation. 2022;145:e773-e774.
    PubMed    


  24. SONG R, Dasgupta C, Mulder C, Zhang L, et al
    MicroRNA-210 Controls Mitochondrial Metabolism and Protects Heart Function in Myocardial Infarction.
    Circulation. 2022 Mar 17. doi: 10.1161/CIRCULATIONAHA.121.056929.
    PubMed     Abstract available



  25. Correction to: 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2022;145:e772.
    PubMed    



  26. Correction to: 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2022;145:e771.
    PubMed    


  27. MARK DB, Spertus JA, Bigelow R, Anderson S, et al
    Comprehensive Quality of Life Outcomes with Invasive versus Conservative Management of Chronic Coronary Disease in ISCHEMIA.
    Circulation. 2022 Mar 9. doi: 10.1161/CIRCULATIONAHA.121.057363.
    PubMed     Abstract available


  28. NAGAREDDY PR, Sreejit G
    Letter by Nagareddy and Sreejit Regarding Article, "Interleukin-1alpha Is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney Disease".
    Circulation. 2022;145:e762-e763.
    PubMed    


  29. SCHUNK SJ, Speer T
    Response by Schunk and Speer to the Letter Regarding Article, "Interleukin-1alpha Is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney Disease".
    Circulation. 2022;145:e764.
    PubMed    


  30. MAAMARI DJ, Jaffer FA, Khera AV, Fahed AC, et al
    CYP2C19 Genotyping in Anticoagulated Patients After Percutaneous Coronary Intervention: Should It Be Routine?
    Circulation. 2022;145:721-723.
    PubMed    


  31. FENG G, Bajpai G, Ma P, Koenig A, et al
    CCL17 Aggravates Myocardial Injury by Suppressing Recruitment of Regulatory T Cells.
    Circulation. 2022;145:765-782.
    PubMed     Abstract available


  32. KOHLI-LYNCH CN, Lewsey J, Boyd KA, French DD, et al
    Beyond Ten-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease.
    Circulation. 2022 Mar 7. doi: 10.1161/CIRCULATIONAHA.121.057631.
    PubMed     Abstract available



  33. Correction to: 2021 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Neonatal Life Support; Education, Implem
    Circulation. 2022;145:e760.
    PubMed    


  34. LAWLER PR, Hochman JS, Zarychanski R
    What Are Adaptive Platform Clinical Trials and What Role May They Have in Cardiovascular Medicine?
    Circulation. 2022;145:629-632.
    PubMed    


    February 2022
  35. OPSTAL TSJ, van Broekhoven A, Fiolet ATL, Mosterd A, et al
    Long-Term Efficacy of Colchicine in Patients With Chronic Coronary Disease: Insights From LoDoCo2.
    Circulation. 2022;145:626-628.
    PubMed    


  36. INDOLFI C, Esposito G
    Universal Health Care System and Cardiovascular Disease Burden in Italy.
    Circulation. 2022;145:559-561.
    PubMed    


  37. LAM CSP
    How to Incorporate Sex and Gender Into the Design of Cardiovascular Clinical Trials.
    Circulation. 2022;145:499-501.
    PubMed    


  38. ANDROULAKIS E, Azzu A, Papagkikas P, Antonopoulos A, et al
    Spontaneous Coronary Artery Dissection: Insights From Cardiac Magnetic Resonance and Extracoronary Arterial Screening.
    Circulation. 2022;145:555-557.
    PubMed    


  39. LINDLEY KJ
    Call for Action to Address Increasing Maternal Cardiovascular Mortality in the United States: Strategies for Improving Maternal Cardiovascular Care.
    Circulation. 2022;145:502-504.
    PubMed    


  40. GONZALEZ-JUANATEY JR, Lemesle G, Puymirat E, Ducrocq G, et al
    One-Year Major Cardiovascular Events After Restrictive Versus Liberal Blood Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Trial.
    Circulation. 2022;145:486-488.
    PubMed    


  41. MESSERLI FH, Bavishi C, Bangalore S
    Why Are We Still Prescribing Angiotensin-Converting Enzyme Inhibitors?
    Circulation. 2022;145:413-415.
    PubMed    


  42. GAO P, You M, Li L, Zhang Q, et al
    Salt-Induced Hepatic Inflammatory Memory Contributes to Cardiovascular Damage Through Epigenetic Modulation of SIRT3.
    Circulation. 2022;145:375-391.
    PubMed     Abstract available


  43. LLOYD-JONES DM
    The Power of Patient Stories to Inspire Us to Prevent Cardiovascular Disease and Death: Personal Reflections on the AHA's Scientific Sessions 2021.
    Circulation. 2022;145:e143-e145.
    PubMed    


  44. ENAS EA, Varkey B
    Letter by Enas and Varkey Regarding Article, "Quantifying and Understanding the Higher Risk of Atherosclerotic Cardiovascular Disease Among South Asian Individuals: Results From the UK Biobank Prospective Cohort Study".
    Circulation. 2022;145:e146.
    PubMed    


  45. PATEL AP, Khera AV
    Response by Patel and Khera to Letter Regarding Article, "Quantifying and Understanding the Higher Risk of Atherosclerotic Cardiovascular Disease Among South Asian Individuals: Results From the UK Biobank Prospective Cohort Study".
    Circulation. 2022;145:e147-e148.
    PubMed    


    January 2022
  46. HASBANI NR, Ligthart S, Brown MR, Heath AS, et al
    American Heart Association's Life's Simple 7: Lifestyle Recommendations, Polygenic Risk, and Lifetime Risk of Coronary Heart Disease.
    Circulation. 2022 Jan 31. doi: 10.1161/CIRCULATIONAHA.121.053730.
    PubMed     Abstract available


  47. ABOULEISA RRE, Salama ABM, Ou Q, Tang XL, et al
    Transient Cell Cycle Induction in Cardiomyocytes to Treat Subacute Ischemic Heart Failure.
    Circulation. 2022 Jan 21. doi: 10.1161/CIRCULATIONAHA.121.057641.
    PubMed     Abstract available


  48. CHEW DS, Cowper PA, Al-Khalidi H, Anstrom KJ, et al
    Cost Effectiveness of Coronary-Artery Bypass Surgery versus Medicine in Ischemic Cardiomyopathy: The STICH Randomized Clinical Trial.
    Circulation. 2022 Jan 19. doi: 10.1161/CIRCULATIONAHA.121.056276.
    PubMed     Abstract available


  49. GRUBB KJ, Kirtane AJ
    The Long-Awaited Revascularization Guidelines Are Out: What's In Them?
    Circulation. 2022;145:155-157.
    PubMed    


  50. DE LEMOS JA, McGuire DK, Hill JA
    Celebrating The Next Generation of Cardiovascular Investigators.
    Circulation. 2022;145:91-93.
    PubMed    


  51. JOSEPH JJ, Deedwania P, Acharya T, Aguilar D, et al
    Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association.
    Circulation. 2022 Jan 10:CIR0000000000001040. doi: 10.1161/CIR.0000000000001040.
    PubMed     Abstract available


  52. DEFTEREOS SG, Beerkens FJ, Shah B, Giannopoulos G, et al
    Colchicine in Cardiovascular Disease: In-Depth Review.
    Circulation. 2022;145:61-78.
    PubMed     Abstract available


  53. CHURCHWELL K, Lloyd-Jones DM, Rochat Harris S, Mehta LS, et al
    Policy Change Needed to Improve Maternal Cardiovascular Health.
    Circulation. 2022;145:e1-e3.
    PubMed    


    December 2021
  54. KUEHN BM
    Centering Equity in Cardiovascular Care.
    Circulation. 2021;144:2035-2037.
    PubMed    


  55. LI C, Qu L, Matz AJ, Murphy PA, et al
    AtheroSpectrum Reveals Novel Macrophage Foam Cell gene Signatures Associated with Atherosclerotic Cardiovascular Disease Risk.
    Circulation. 2021 Dec 16. doi: 10.1161/CIRCULATIONAHA.121.054285.
    PubMed     Abstract available


  56. LAWTON JS, Tamis-Holland JE, Bangalore S, Bates ER, et al
    2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2021 Dec 9:CIR0000000000001039. doi: 10.1161/CIR.0000000000001039.
    PubMed     Abstract available


  57. LAWTON JS, Tamis-Holland JE, Bangalore S, Bates ER, et al
    2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2021 Dec 9:CIR0000000000001038. doi: 10.1161/CIR.0000000000001038.
    PubMed     Abstract available


  58. AL RIFAI M, Blaha MJ, Nambi V, Shea SJC, et al
    Determinants of Incident Atherosclerotic Cardiovascular Disease Events Among Those With Absent Coronary Artery Calcium: Multi-Ethnic Study of Atherosclerosis.
    Circulation. 2021 Dec 8. doi: 10.1161/CIRCULATIONAHA.121.056705.
    PubMed     Abstract available


  59. CHANG Q, Xu Z, Liu R
    Acute Inferior Wall Myocardial Infarction: What Is the Culprit Artery?
    Circulation. 2021;144:1893-1895.
    PubMed    


  60. LAMBRAKIS K, Chew DP
    Response by Lambrakis and Chew to Letter Regarding Article, "Late Outcomes of the RAPID-TnT Randomized Controlled Trial: 0/1-Hour High-Sensitivity Troponin T Protocol in Suspected ACS".
    Circulation. 2021;144:e459-e460.
    PubMed    


  61. CHIANG CH, Chiang CH, Lee CC
    Letter by Chiang et al Regarding Article, "Late Outcomes of the RAPID-TnT Randomized Controlled Trial: 0/1-Hour High-Sensitivity Troponin T Protocol in Suspected ACS".
    Circulation. 2021;144:e457-e458.
    PubMed    


    November 2021
  62. KATZ DH, Tahir UA, Bick AG, Pampana A, et al
    Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights into Cardiovascular Disease.
    Circulation. 2021 Nov 24. doi: 10.1161/CIRCULATIONAHA.121.055117.
    PubMed     Abstract available


  63. SREEJIT G, Nooti SK, Jaggers RM, Athmanathan B, et al
    Retention of the NLRP3 Inflammasome-primed Neutrophils in the Bone Marrow is Essential for Myocardial Infarction-induced Granulopoiesis.
    Circulation. 2021 Nov 17. doi: 10.1161/CIRCULATIONAHA.121.056019.
    PubMed     Abstract available


  64. RAMAN B, Tunnicliffe EM, Chan K, Ariga R, et al
    Association Between Sarcomeric Variants in Hypertrophic Cardiomyopathy and Myocardial Oxygenation: Insights From a Novel Oxygen-Sensitive Cardiovascular Magnetic Resonance Approach.
    Circulation. 2021;144:1656-1658.
    PubMed    


  65. LAI Y, Zhuang X, Liao X
    Letter by Lai et al Regarding Article, "Cardiovascular Risk Factor Trajectories Since Childhood and Cognitive Performance in Midlife: The Cardiovascular Risk in Young Finns Study".
    Circulation. 2021;144:e307.
    PubMed    


  66. HAKALA JO, Raitakari OT, Rovio SP
    Response by Hakala et al to Letter Regarding Article, "Cardiovascular Risk Factor Trajectories Since Childhood and Cognitive Performance in Midlife: The Cardiovascular Risk in Young Finns Study".
    Circulation. 2021;144:e308-e309.
    PubMed    


  67. WYCKOFF MH, Singletary EM, Soar J, Olasveengen TM, et al
    2021 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Neonatal Life Support; Education, Implementation, and T
    Circulation. 2021 Nov 11:CIR0000000000001017. doi: 10.1161/CIR.0000000000001017.
    PubMed     Abstract available


  68. ZAHA VG, Hayek SS, Alexander KM, Beckie TM, et al
    Future Perspectives of Cardiovascular Biomarker Utilization in Cancer Survivors: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Nov 10:CIR0000000000001032. doi: 10.1161/CIR.0000000000001032.
    PubMed     Abstract available



  69. Correction to: Combined Associations of Changes in Noncombustible Nicotine or Tobacco Product and Combustible Cigarette Use Habits With Subsequent Short-Term Cardiovascular Disease Risk Among South Korean Men: A Nationwide Cohort Study.
    Circulation. 2021;144:e306.
    PubMed    


  70. TONG DC, Bloom JE, Quinn S, Nasis A, et al
    Colchicine in Patients With Acute Coronary Syndrome: Two-Year Follow-Up of the Australian COPS Randomized Clinical Trial.
    Circulation. 2021;144:1584-1586.
    PubMed    


  71. SCHAEFER I, Lopez-Ayala P, Mueller C
    Letter by Schaefer et al Regarding Article, "Diagnostic Performance of High-Sensitivity Cardiac Troponin T Strategies and Clinical Variables in a Multisite US Cohort".
    Circulation. 2021;144:e283-e284.
    PubMed    


  72. ALLEN BR, Christenson RH, Cohen SA, Weaver MT, et al
    Response by Allen et al to Letter Regarding Article, "Diagnostic Performance of High-Sensitivity Cardiac Troponin T Strategies and Clinical Variables in a Multisite US Cohort".
    Circulation. 2021;144:e285-e286.
    PubMed    


  73. AUER R, Diethelm P, Berthet A
    Heating Tobacco Sticks Instead of Combusting Conventional Cigarettes and Future Heart Attacks: Still Smoke, and Risk.
    Circulation. 2021;144:1539-1542.
    PubMed    


  74. RUETZLER K, Smilowitz NR, Berger JS, Devereaux PJ, et al
    Diagnosis and Management of Patients With Myocardial Injury After Noncardiac Surgery: A Scientific Statement From the American Heart Association.
    Circulation. 2021;144:e287-e305.
    PubMed     Abstract available


  75. LADDU D, Ma J, Kaar J, Ozemek C, et al
    Health Behavior Change Programs in Primary Care and Community Practices for Cardiovascular Disease Prevention and Risk Factor Management Among Midlife and Older Adults: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Nov 4:CIR0000000000001026. doi: 10.1161/CIR.0000000000001026.
    PubMed     Abstract available


  76. MICHOS ED, Udell JA
    Am I Getting the Influenza Shot Too?: Influenza Vaccination as Post-Myocardial Infarction Care for the Prevention of Cardiovascular Events and Death.
    Circulation. 2021;144:1485-1488.
    PubMed    


  77. CHUANG YT, Ueng KC, Tsai CF
    Grouped Beating After Acute Inferior Myocardial Infarction.
    Circulation. 2021;144:1518-1520.
    PubMed    


  78. LICHTENSTEIN AH, Appel LJ, Vadiveloo M, Hu FB, et al
    2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Nov 2:CIR0000000000001031. doi: 10.1161/CIR.0000000000001031.
    PubMed     Abstract available


  79. COWIE MR, Deanfield J
    Cardiovascular Medicine at a Crossroads in the United Kingdom.
    Circulation. 2021;144:1457-1458.
    PubMed    


  80. MCNALLY EM, Elkind MSV, Benjamin IJ, Chung MK, et al
    Impact of the COVID-19 Pandemic on Cardiovascular Science: Anticipating Problems and Potential Solutions: A Presidential Advisory From the American Heart Association.
    Circulation. 2021 Nov 1:CIR0000000000001027. doi: 10.1161/CIR.0000000000001027.
    PubMed     Abstract available


    October 2021
  81. VERMA S, Bhatt DL, Steg PG, Miller M, et al
    Icosapent Ethyl Reduces Ischemic Events in Patients with a History of Prior Coronary Artery Bypass Grafting: REDUCE-IT CABG.
    Circulation. 2021 Oct 28. doi: 10.1161/CIRCULATIONAHA.121.056290.
    PubMed     Abstract available


  82. MAJITHIA A, Bhatt DL, Friedman AN, Miller M, et al
    Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients with Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL.
    Circulation. 2021 Oct 28. doi: 10.1161/CIRCULATIONAHA.121.055560.
    PubMed     Abstract available


  83. YAZAKI Y, Nakamura M, Iijima R, Yasuda S, et al
    Clinical Outcomes of Rivaroxaban Monotherapy in Heart Failure Patients With Atrial Fibrillation and Stable Coronary Disease: Insights From the AFIRE Trial.
    Circulation. 2021;144:1449-1451.
    PubMed    


  84. BRAILLON A
    Letter by Braillon Regarding Article, "Very High Coronary Artery Calcium (>/=1000) and Association With Cardiovascular Disease Events, Non-Cardiovascular Disease Outcomes, and Mortality: Results From MESA".
    Circulation. 2021;144:e274.
    PubMed    


  85. PENG AW, Dardari ZA, Blaha MJ
    Response by Peng et al to Letter Regarding Article, "Very High Coronary Artery Calcium (>/=1000) and Association With Cardiovascular Disease Events, Non-Cardiovascular Disease Outcomes, and Mortality: Results From MESA".
    Circulation. 2021;144:e275-e276.
    PubMed    


  86. NEELAND IJ, McGuire DK, Sattar N
    Cardiovascular Outcomes Trials for Weight Loss Interventions: Another Tool for Cardiovascular Prevention?
    Circulation. 2021;144:1359-1361.
    PubMed    


  87. SANCHEZ-LOPEZ A, Espinos-Estevez C, Gonzalez-Gomez C, Gonzalo P, et al
    Cardiovascular Progerin Suppression and lamin A Restoration Rescues Hutchinson-Gilford Progeria Syndrome.
    Circulation. 2021 Oct 25. doi: 10.1161/CIRCULATIONAHA.121.055313.
    PubMed     Abstract available


  88. KRIS-ETHERTON PM, Petersen KS, Despres JP, Anderson CAM, et al
    Strategies for Promotion of a Healthy Lifestyle in Clinical Settings: Pillars of Ideal Cardiovascular Health: A Science Advisory From the American Heart Association.
    Circulation. 2021 Oct 25:CIR0000000000001018. doi: 10.1161/CIR.0000000000001018.
    PubMed     Abstract available


  89. ALE-AGHA N, Jakobs P, Goy C, Zurek M, et al
    Mitochondrial Telomerase Reverse Transcriptase Protects from Myocardial Ischemia/reperfusion Injury by Improving Complex I Composition and Function.
    Circulation. 2021 Oct 21. doi: 10.1161/CIRCULATIONAHA.120.051923.
    PubMed     Abstract available



  90. Correction to: Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial.
    Circulation. 2021;144:e273.
    PubMed    


  91. KHAN SU, Javed Z, Lone AN, Dani SS, et al
    Social Vulnerability and Premature Cardiovascular Mortality Among US Counties, 2014 to 2018.
    Circulation. 2021;144:1272-1279.
    PubMed     Abstract available


  92. GANGAVELLI A, Morris AA
    Premature Cardiovascular Mortality in the United States: Who Will Protect the Most Vulnerable Among Us?
    Circulation. 2021;144:1280-1283.
    PubMed    


  93. JACOBS AK, Ali MJ, Best PJ, Bieniarz MC, et al
    Systems of Care for ST-Segment-Elevation Myocardial Infarction: A Policy Statement From the American Heart Association.
    Circulation. 2021 Oct 13:CIR0000000000001025. doi: 10.1161/CIR.0000000000001025.
    PubMed     Abstract available


  94. LEE LY, Oldham WM, He H, Wang R, et al
    Interferon-gamma Impairs Human Coronary Artery Endothelial Glucose Metabolism via Tryptophan Catabolism and Activates Fatty Acid Oxidation.
    Circulation. 2021 Oct 12. doi: 10.1161/CIRCULATIONAHA.121.053960.
    PubMed     Abstract available


  95. GENCER B, Djousse L, Al-Ramady OT, Cook NR, et al
    Effect of Long-Term Marine Omega-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.
    Circulation. 2021 Oct 6. doi: 10.1161/CIRCULATIONAHA.121.055654.
    PubMed     Abstract available


  96. GAUDINO M, Sandner S, Di Giammarco G, Di Franco A, et al
    The Use of Intraoperative Transit Time Flow Measurement for Coronary Artery Bypass Surgery: Systematic Review of the Evidence and Expert Opinion Statements.
    Circulation. 2021;144:1160-1171.
    PubMed     Abstract available


  97. RUEL M, Fischbein M
    Introduction to the 2021 Cardiovascular Surgery Themed Issue of Circulation.
    Circulation. 2021;144:1087.
    PubMed    


  98. CHOI S, Lee K, Park SM
    Combined Associations of Changes in Noncombustible Nicotine or Tobacco Product and Combustible Cigarette Use Habits With Subsequent Short-Term Cardiovascular Disease Risk Among South Korean Men: A Nationwide Cohort Study.
    Circulation. 2021 Oct 4. doi: 10.1161/CIRCULATIONAHA.121.054967.
    PubMed    


    September 2021

  99. Correction to: Selective Stimulation of Cardiac Lymphangiogenesis Reduces Myocardial Edema and Fibrosis Leading to Improved Cardiac Function Following Myocardial Infarction.
    Circulation. 2021;144:e213.
    PubMed    


  100. ALLARD-RATICK MP, McCarthy CP, Jang IK
    Letter by Allard-Ratick et al Regarding Article, "Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women".
    Circulation. 2021;144:e206.
    PubMed    


  101. MATTA A, Elbaz M, Roncalli J
    Letter by Matta et al Regarding Article, "Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women".
    Circulation. 2021;144:e204.
    PubMed    


  102. HAMILTON GW, Tan S, Layland J
    Letter by Hamilton et al Regarding Article, "Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women".
    Circulation. 2021;144:e207-e208.
    PubMed    


  103. REYNOLDS HR, Kwong RY, Maehara A, Smilowitz NR, et al
    Response by Reynolds et al to Letters Regarding Article, "Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women".
    Circulation. 2021;144:e209-e210.
    PubMed    


  104. NGUYEN TH, Ong GJ, Horowitz JD
    Letter by Nguyen et al Regarding Article, "Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women".
    Circulation. 2021;144:e205.
    PubMed    


  105. BERGSTROM G, Persson M, Adiels M, Bjornson E, et al
    Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population.
    Circulation. 2021;144:916-929.
    PubMed     Abstract available


  106. GENTILE F, Castiglione V, De Caterina R
    Coronary Artery Anomalies.
    Circulation. 2021;144:983-996.
    PubMed     Abstract available


  107. KUEHN BM
    Increasing Burnout Could Have Dire Effects on the Cardiovascular Workforce After the Pandemic.
    Circulation. 2021;144:997-999.
    PubMed    


  108. MERID B, Robles MC, Nallamothu BK
    Digital Redlining and Cardiovascular Innovation.
    Circulation. 2021;144:913-915.
    PubMed    


  109. KEN LEE K, Wereski R, Williams MC, Mills NL, et al
    Population Screening With Coronary Computed Tomography Angiography and the Prevention of Coronary Events.
    Circulation. 2021;144:930-933.
    PubMed    


  110. REDD MA, Scheuer SE, Saez NJ, Yoshikawa Y, et al
    Therapeutic Inhibition of Acid-Sensing Ion Channel 1a Recovers Heart Function After Ischemia-Reperfusion Injury.
    Circulation. 2021;144:947-960.
    PubMed     Abstract available


  111. FILIPPATOS G, Agarwal R, Bakris G, Anker S, et al
    Response by Filippatos et al to Letter Regarding Article, "Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes".
    Circulation. 2021;144:e202-e203.
    PubMed    


  112. LOTHER A, Bode C, Hein L
    Letter by Lother et al Regarding Article, "Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes".
    Circulation. 2021;144:e201.
    PubMed    


  113. SATTLER S
    Single-Cell Immunology in Cardiovascular Medicine: Do We Know Yet What We Do Not Know?
    Circulation. 2021;144:843-844.
    PubMed    


  114. TIAN M, Wang X, Sun H, Feng W, et al
    No-Touch Versus Conventional Vein Harvesting Techniques at 12 Months After Coronary Artery Bypass Grafting Surgery: Multicenter Randomized, Controlled Trial.
    Circulation. 2021 Sep 13. doi: 10.1161/CIRCULATIONAHA.121.055525.
    PubMed    


  115. REYNOLDS HR, Shaw LJ, Min JK, Page CB, et al
    Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity.
    Circulation. 2021 Sep 9. doi: 10.1161/CIRCULATIONAHA.120.049755.
    PubMed     Abstract available


  116. LOPEZ-AYALA P, Nestelberger T, Boeddinghaus J, Koechlin L, et al
    Novel Criteria for the Observe-Zone of the ESC 0/1h-hs-cTnT Algorithm.
    Circulation. 2021;144:773-787.
    PubMed     Abstract available


    August 2021
  117. HASSELBALCH RB, Bundgaard H, Iversen KK
    Response by Hasselbalch et al to Letter Regarding Article, "Temporal Release of High-Sensitivity Cardiac Troponin T and I and Copeptin After Brief Induced Coronary Artery Balloon Occlusion in Humans".
    Circulation. 2021;144:e169-e170.
    PubMed    


  118. SANDOVAL Y, Jaffe AS
    Letter by Sandoval and Jaffe Regarding Article, "Temporal Release of High-Sensitivity Cardiac Troponin T and I and Copeptin After Brief Induced Coronary Artery Balloon Occlusion in Humans".
    Circulation. 2021;144:e168.
    PubMed    


  119. HWANG P, Schulz R, Kavsak P
    Letter by Hwang et al Regarding Article, "Temporal Release of High-Sensitivity Cardiac Troponin T and I and Copeptin After Brief Induced Coronary Artery Balloon Occlusion in Humans".
    Circulation. 2021;144:e166-e167.
    PubMed    


  120. XENOGIANNIS I, Zenati M, Bhatt DL, Rao SV, et al
    Saphenous Vein Graft Failure: From Pathophysiology to Prevention and Treatment Strategies.
    Circulation. 2021;144:728-745.
    PubMed     Abstract available


  121. RAJENDRAN G, Muthanikkatt AM, Nathan B
    Not All Waves Are Factual.
    Circulation. 2021;144:751-753.
    PubMed    


  122. FROBERT O, Gotberg M, Erlinge D, Akhtar Z, et al
    Influenza Vaccination after Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.
    Circulation. 2021 Aug 30. doi: 10.1161/CIRCULATIONAHA.121.057042.
    PubMed     Abstract available


  123. LOPES RD, Higano CS, Slovin SF, Nelson AJ, et al
    Cardiovascular Safety of Degarelix versus Leuprolide in Patients with Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial.
    Circulation. 2021 Aug 30. doi: 10.1161/CIRCULATIONAHA.121.056810.
    PubMed     Abstract available


  124. SMITS PC, Frigoli E, Tijssen J, Juni P, et al
    Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial.
    Circulation. 2021 Aug 29. doi: 10.1161/CIRCULATIONAHA.121.056680.
    PubMed     Abstract available


  125. MARSTON NA, Giugliano RP, Park JG, Ruzza A, et al
    Cardiovascular Benefit of Lowering LDL Cholesterol Below 40 mg/dl.
    Circulation. 2021 Aug 27. doi: 10.1161/CIRCULATIONAHA.121.056536.
    PubMed    



  126. Correction to: Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction.
    Circulation. 2021;144:e164.
    PubMed    


  127. LACKEY LG, Garnett CE, Senatore F
    Applying Decision Analysis to Inform the US Food and Drug Administration's Benefit-Risk Assessment of Ticagrelor for Primary Prevention of Myocardial Infarction or Stroke Based on THEMIS.
    Circulation. 2021;144:655-658.
    PubMed    


  128. DANG TA, Kessler T, Wobst J, Wierer M, et al
    Identification of a Functional PDE5A Variant at the Chromosome 4q27 Coronary Artery Disease Locus in an Extended Myocardial Infarction Family.
    Circulation. 2021;144:662-665.
    PubMed    


  129. MATSKEPLISHVILI S, Kontsevaya A
    Cardiovascular Health, Disease, and Care in Russia.
    Circulation. 2021;144:586-588.
    PubMed    


  130. MEWTON N, Roubille F, Bresson D, Prieur C, et al
    Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction.
    Circulation. 2021 Aug 23. doi: 10.1161/CIRCULATIONAHA.121.056177.
    PubMed    


  131. CHOW SL, Sasson C, Benjamin IJ, Califf RM, et al
    Opioid Use and Its Relationship to Cardiovascular Disease and Brain Health: A Presidential Advisory From the American Heart Association.
    Circulation. 2021 Aug 19:CIR0000000000001007. doi: 10.1161/CIR.0000000000001007.
    PubMed     Abstract available


  132. WATERS DD, Stone GW
    Usefulness of Angina to Guide Revascularization Decisions.
    Circulation. 2021;144:524-527.
    PubMed    


  133. MESNIER J, Ducrocq G, Danchin N, Ferrari R, et al
    International Observational Analysis of Evolution and Outcomes of Chronic Stable Angina: The Multinational CLARIFY Study.
    Circulation. 2021;144:512-523.
    PubMed     Abstract available



  134. Correction to: Assessing and Addressing Cardiovascular Health in People Who Are Transgender and Gender Diverse: A Scientific Statement From the American Heart Association.
    Circulation. 2021;144:e150.
    PubMed    


  135. GOLDSTEIN LN, Wu MT, Wells M
    Does This Ischemic Pattern Look Right?
    Circulation. 2021;144:499-501.
    PubMed    


  136. SANKARDAS MA, Ramakumar V, Farooqui FA
    Of Occlusions, Inclusions, and Exclusions: Time to Reclassify Infarctions?
    Circulation. 2021;144:333-335.
    PubMed    


    July 2021
  137. JOYNT MADDOX KE, Gilstrap LG
    Is Rising Cardiovascular Spending a Good News or Bad News Story?
    Circulation. 2021;144:283-285.
    PubMed    


  138. REAL C, Morales T, Viana-Tejedor A
    An Unusual Call From the Urology Ward.
    Circulation. 2021;144:324-327.
    PubMed    


  139. PIRILLO A, Catapano AL
    Omega-3 for Cardiovascular Diseases: Where Do We Stand After REDUCE-IT and STRENGTH?
    Circulation. 2021;144:183-185.
    PubMed    


  140. SRIDHARAN A, Han JK, Feliciano Z
    An Ominous ECG.
    Circulation. 2021;144:246-248.
    PubMed    


  141. CHAITMAN BR, Reynolds HR, Maron DJ, Hochman JS, et al
    Response by Chaitman et al to Letter Regarding Article, "Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons".
    Circulation. 2021;144:e14-e15.
    PubMed    


  142. CORREIA LCL, Viana MS
    Letter by Correia and Viana Regarding Article, "Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons".
    Circulation. 2021;144:e12-e13.
    PubMed    



  143. Retraction and Replacement of: Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG): A Randomized, Double-Blind, Placebo-Controlled Trial.
    Circulation. 2021;144:e36.
    PubMed    


  144. MEHTA SR
    Achieving Complete Revascularization for Multivessel Coronary Artery Disease.
    Circulation. 2021;144:110-112.
    PubMed    


  145. LAMBRAKIS K, Papendick C, French JK, Quinn S, et al
    Late Outcomes of the RAPID-TnT Randomized Controlled Trial: 0/1-Hour High-Sensitivity Troponin T Protocol in Suspected ACS.
    Circulation. 2021;144:113-125.
    PubMed     Abstract available


  146. PATEL AP, Wang M, Kartoun U, Ng K, et al
    Quantifying and Understanding the Higher Risk of Atherosclerotic Cardiovascular Disease Among South Asian Individuals: Results From the UK Biobank Prospective Cohort Study.
    Circulation. 2021 Jul 12. doi: 10.1161/CIRCULATIONAHA.120.052430.
    PubMed    


  147. STREED CG JR, Beach LB, Caceres BA, Dowshen NL, et al
    Assessing and Addressing Cardiovascular Health in People Who Are Transgender and Gender Diverse: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Jul 8:CIR0000000000001003. doi: 10.1161/CIR.0000000000001003.
    PubMed     Abstract available


  148. ZHANG Q, Burrage MK, Lukaschuk E, Shanmuganathan M, et al
    Towards Replacing Late Gadolinium Enhancement with Artificial Intelligence Virtual Native Enhancement for Gadolinium-Free Cardiovascular Magnetic Resonance Tissue Characterization in Hypertrophic Cardiomyopathy.
    Circulation. 2021 Jul 7. doi: 10.1161/CIRCULATIONAHA.121.054432.
    PubMed     Abstract available


  149. LI Y, Lu G
    Letter by Li and Lu Regarding Article, "Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry".
    Circulation. 2021;144:e6-e7.
    PubMed    


  150. HENDREN NS, de Lemos JA, Grodin JL
    Response by Hendren et al to Letter Regarding Article, "Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry".
    Circulation. 2021;144:e8-e9.
    PubMed    


  151. NELSON AJ, Pagidipati NJ, Aroda VR, Cavender MA, et al
    Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community.
    Circulation. 2021;144:74-84.
    PubMed     Abstract available


  152. SCHUNK SJ, Triem S, Schmit D, Zewinger S, et al
    Interleukin-1alpha (IL-1alpha) is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney Disease.
    Circulation. 2021 Jul 1. doi: 10.1161/CIRCULATIONAHA.121.053547.
    PubMed     Abstract available


    June 2021
  153. WERESKI R, Kimenai DM, Taggart C, Doudesis D, et al
    Cardiac Troponin Thresholds and Kinetics to Differentiate Myocardial Injury and Myocardial Infarction.
    Circulation. 2021 Jun 25. doi: 10.1161/CIRCULATIONAHA.121.054302.
    PubMed     Abstract available



  154. Correction to: A Randomized Trial of a 1-Hour Troponin T Protocol in Suspected Acute Coronary Syndromes: The Rapid Assessment of Possible Acute Coronary Syndrome in the Emergency Department With High-Sensitivity Troponin T Study (RAPID-TnT).
    Circulation. 2021;143:e1118.
    PubMed    



  155. Correction to: Temporal Release of High-Sensitivity Cardiac Troponin T and I and Copeptin After Brief Induced Coronary Artery Balloon Occlusion in Humans.
    Circulation. 2021;143:e1116.
    PubMed    


  156. DROBNI ZD, Mayrhofer T, Hoffmann U, Neilan TG, et al
    Response to Sarayani et al Regarding Article, "Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque".
    Circulation. 2021;143:e1033-e1034.
    PubMed    


  157. SARAYANI A, Jugl S, Winterstein AG
    Letter by Sarayani et al Regarding Article, "Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque".
    Circulation. 2021;143:e1031-e1032.
    PubMed    


  158. REILLY MP, Bornfeldt KE
    Integrative Multiomics Approaches for Discovery of New Drug Targets for Cardiovascular Disease.
    Circulation. 2021;143:2471-2474.
    PubMed    


  159. YEGHIAZARIANS Y, Jneid H, Tietjens JR, Redline S, et al
    Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Jun 21:CIR0000000000000988. doi: 10.1161/CIR.0000000000000988.
    PubMed     Abstract available


  160. DAMLUJI AA, van Diepen S, Katz JN, Menon V, et al
    Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Jun 15:CIR0000000000000985. doi: 10.1161/CIR.0000000000000985.
    PubMed     Abstract available


  161. ALBERT MA, Carnethon MR, Watson KE
    Disparities in Cardiovascular Medicine.
    Circulation. 2021;143:2319-2320.
    PubMed    


  162. LEE H, Yano Y, Cho SMJ, Lee HH, et al
    Associations of Ideal Cardiovascular Health and Its Change During Young Adulthood With Premature Cardiovascular Events: A Nationwide Cohort Study.
    Circulation. 2021 Jun 14. doi: 10.1161/CIRCULATIONAHA.121.054212.
    PubMed    


  163. MEUWESE CL, Kraaijeveld AO, Donker DW
    Letter by Meuwese et al Regarding Article, "Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: Results From an International, Multicenter Coho
    Circulation. 2021;143:e1022-e1023.
    PubMed    


  164. SCHRAGE B, Westermann D
    Response by Schrage and Westermann to Letters Regarding Article, "Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: Results From an Internati
    Circulation. 2021;143:e1024.
    PubMed    


  165. MEHMOOD M
    Letter by Mehmood Regarding Article, "Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: Results From an International, Multicenter Cohort Stu
    Circulation. 2021;143:e1021.
    PubMed    


  166. REYNOLDS HR, Picard MH, Spertus JA, Peteiro J, et al
    Natural History of Patients with Ischemia and No Obstructive Coronary Artery Disease: The CIAO-ISCHEMIA Study.
    Circulation. 2021 Jun 1. doi: 10.1161/CIRCULATIONAHA.120.046791.
    PubMed     Abstract available


  167. EDELMAN ER
    Karnovsky's Dictum: The Endothelium Is Good-Looking and Smart.
    Circulation. 2021;143:2166-2168.
    PubMed    


    May 2021
  168. ALTHOUSE AD, Below JE, Claggett BL, Cox NJ, et al
    Recommendations for Statistical Reporting in Cardiovascular Medicine: A Special Report From the American Heart Association.
    Circulation. 2021 May 25:CIRCULATIONAHA121055393.
    PubMed     Abstract available


  169. KARIO K, Kanegae H, Hoshide S
    Response by Kario et al to Letter Regarding Article, "Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study".
    Circulation. 2021;143:e982-e983.
    PubMed    


  170. CHANG AY, Barry M, Harrington RA
    The Need to Expand the Framework of Environmental Determinants of Cardiovascular Health From Climate Change to Planetary Health: Trial by Wildfire.
    Circulation. 2021;143:2029-2031.
    PubMed    


  171. PENGO MF, Bisogni V, Martinez-Garcia MA
    Letter by Pengo et al Regarding Article, "Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study".
    Circulation. 2021;143:e980-e981.
    PubMed    


  172. ISOMI M, Sadahiro T, Yamakawa H, Fujita R, et al
    Overexpression of Gata4, Mef2c, and Tbx5 Generates Induced Cardiomyocytes Via Direct Reprogramming and Rare Fusion in the Heart.
    Circulation. 2021;143:2123-2125.
    PubMed    


  173. GAO R, Wang L, Bei Y, Wu X, et al
    LncRNA CPhar Induces Cardiac Physiological Hypertrophy and Promotes Functional Recovery After Myocardial Ischemia-Reperfusion Injury.
    Circulation. 2021 May 21. doi: 10.1161/CIRCULATIONAHA.120.050446.
    PubMed     Abstract available


  174. TAKAHASHI K, Serruys PW, Gao C, Ono M, et al
    Ten-Year All-Cause Death According to Completeness of Revascularization in Patients with Three-Vessel Disease or Left Main Coronary Artery Disease: Insights from the SYNTAX Extended Survival Study.
    Circulation. 2021 May 20. doi: 10.1161/CIRCULATIONAHA.120.046289.
    PubMed     Abstract available


  175. LOPES RD, Alexander KP, Hochman JS, Maron DJ, et al
    Response by Lopes et al to Letter Regarding Article, "Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial".
    Circulation. 2021;143:e961-e962.
    PubMed    


  176. MORGAN H, Clayton T, Perera D
    Letter by Morgan et al Regarding Article, "Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial".
    Circulation. 2021;143:e959-e960.
    PubMed    


  177. ROHATGI A
    Stressing the Endothelium to Assess Localized Inflammatory Potential and the Risk for Atherosclerotic Cardiovascular Disease.
    Circulation. 2021;143:1946-1948.
    PubMed    


  178. KUWABARA M, Mori M, Komoto S
    Japanese National Plan for Promotion of Measures Against Cerebrovascular and Cardiovascular Disease.
    Circulation. 2021;143:1929-1931.
    PubMed    


  179. DOCHERTY KF, Campbell RT, Brooksbank KJM, Dreisbach JG, et al
    The Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients with Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction.
    Circulation. 2021 May 13. doi: 10.1161/CIRCULATIONAHA.121.054892.
    PubMed     Abstract available


  180. HENDRICKSON BS, Stephens RE, Chang JV, Amburn JM, et al
    Cardiovascular Evaluation After COVID-19 in 137 Collegiate Athletes: Results of an Algorithm-Guided Screening.
    Circulation. 2021;143:1926-1928.
    PubMed    


  181. HAKALA JO, Pahkala K, Juonala M, Salo P, et al
    Cardiovascular Risk Factor Trajectories Since Childhood and Cognitive Performance in Midlife: The Cardiovascular Risk in Young Finns Study.
    Circulation. 2021 May 10. doi: 10.1161/CIRCULATIONAHA.120.052358.
    PubMed    


  182. ZHAO M, Nakada Y, Wei Y, Bian W, et al
    Cyclin D2 Overexpression Enhances the Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Myocardial Repair in a Swine Model of Myocardial Infarction.
    Circulation. 2021 May 6. doi: 10.1161/CIRCULATIONAHA.120.049497.
    PubMed     Abstract available


  183. TAPIA-ORIHUELA RKA, Gutierrez OJ, Del-Carpio Munoz F
    A "Carousel" ECG Confusion.
    Circulation. 2021;143:1824-1827.
    PubMed    


    April 2021
  184. BIRGER M, Kaldjian AS, Roth GA, Moran AE, et al
    Spending on Cardiovascular Disease and Cardiovascular Risk Factors in the United States: 1996 - 2016.
    Circulation. 2021 Apr 30. doi: 10.1161/CIRCULATIONAHA.120.053216.
    PubMed     Abstract available


  185. SARTO P, Zorzi A, Merlo L, Vessella T, et al
    Serial Versus Single Cardiovascular Screening of Adolescent Athletes.
    Circulation. 2021;143:1729-1731.
    PubMed    


  186. POWELL-WILEY TM, Poirier P, Burke LE, Despres JP, et al
    Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Apr 22:CIR0000000000000973. doi: 10.1161/CIR.0000000000000973.
    PubMed     Abstract available


  187. FIGTREE GA, Broadfoot K, Casadei B, Califf R, et al
    A Call to Action for New Global Approaches to Cardiovascular Disease Drug Solutions.
    Circulation. 2021 Apr 20:CIR0000000000000981. doi: 10.1161/CIR.0000000000000981.
    PubMed     Abstract available


  188. KUEHN BM
    Novel Approaches Expand Access to Cardiovascular Preventive Care.
    Circulation. 2021;143:1629-1630.
    PubMed    


  189. NEAL B, Wu J
    Sodium, Blood Pressure, and the Likely Massive Avoidable Burden of Cardiovascular Disease.
    Circulation. 2021;143:1568-1570.
    PubMed    


  190. SCHAUER PR, Nissen SE
    After 70 Years, Metabolic Surgery Has Earned a Cardiovascular Outcome Trial.
    Circulation. 2021;143:1481-1483.
    PubMed    


  191. JIA C, Anderson JLC, Gruppen EG, Lei Y, et al
    High-Density Lipoprotein Anti-Inflammatory Capacity and Incident Cardiovascular Events.
    Circulation. 2021 Apr 12. doi: 10.1161/CIRCULATIONAHA.120.050808.
    PubMed    


  192. JAKOBSEN L, Christiansen EH, Freeman P, Kahlert J, et al
    Randomized Clinical Comparison of the Dual Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent with the Sirolimus-Eluting Orsiro Stent in Patients Treated with Percutaneous Coronary Intervention: The SORT OUT X Trial.
    Circulation. 2021 Apr 7. doi: 10.1161/CIRCULATIONAHA.120.052766.
    PubMed     Abstract available


  193. BANGALORE S, Maron DJ, Stone GW, Hochman JS, et al
    Response by Bangalore et al to Letter Regarding Article, "Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials".
    Circulation. 2021;143:e809-e810.
    PubMed    


  194. FERRARO R, Arbab-Zadeh A
    Letter by Ferraro and Arbab-Zadeh Regarding Article, "Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials".
    Circulation. 2021;143:e805-e806.
    PubMed    


  195. SHAH R
    Letter by Shah Regarding Article, "Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials".
    Circulation. 2021;143:e807-e808.
    PubMed    


  196. WENGER NK, Lewis SJ
    Incremental Change versus Disruptive Transformation: COVID-19 and the Cardiovascular Community.
    Circulation. 2021 Apr 6. doi: 10.1161/CIRCULATIONAHA.121.053860.
    PubMed    


  197. LANSKY AJ, Kereiakes DJ, Baumbach A, Windecker S, et al
    Novel Supreme(TM) DES with Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation after DES implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical Trial.
    Circulation. 2021 Apr 6. doi: 10.1161/CIRCULATIONAHA.120.052482.
    PubMed     Abstract available


  198. YACOUB M, Labib D
    Toward Meeting the Challenges of Improving Cardiovascular Health in Egypt.
    Circulation. 2021;143:1341-1342.
    PubMed    


  199. SAHOO S, Adamiak M, Mathiyalagan P, Kenneweg F, et al
    Therapeutic and Diagnostic Translation of Extracellular Vesicles in Cardiovascular Diseases: Roadmap to the Clinic.
    Circulation. 2021;143:1426-1449.
    PubMed     Abstract available


  200. DOUMOURAS A, Wong JA, Paterson JM, Lee Y, et al
    Bariatric Surgery and Cardiovascular Outcomes in Patients With Obesity and Cardiovascular Disease: A Population-Based Retrospective Cohort Study.
    Circulation. 2021 Apr 5. doi: 10.1161/CIRCULATIONAHA.120.052386.
    PubMed    


    March 2021
  201. GARGIULO G, Nagler M, Valgimigli M
    Response by Gargiulo et al to Letter Regarding Article, "Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial".
    Circulation. 2021;143:e797-e798.
    PubMed    


  202. ANGIOLILLO DJ, Bhatt DL, Stone GW
    Letter by Angiolillo et al Regarding Article, "Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial".
    Circulation. 2021;143:e795-e796.
    PubMed    


  203. PARIKH NI, Gonzalez JM, Anderson CAM, Judd SE, et al
    Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Mar 29:CIR0000000000000961. doi: 10.1161/CIR.0000000000000961.
    PubMed     Abstract available


  204. ANAND A, Lee KK, Chapman AR, Ferry AV, et al
    High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Controlled Trial.
    Circulation. 2021 Mar 23. doi: 10.1161/CIRCULATIONAHA.120.052380.
    PubMed     Abstract available



  205. Correction to: Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association.
    Circulation. 2021;143:e792-e793.
    PubMed    


  206. DEFILIPPI CR, Mills NL
    Rapid Cardiac Troponin Release After Transient Ischemia: Implications for the Diagnosis of Myocardial Infarction.
    Circulation. 2021;143:1105-1108.
    PubMed    


  207. JANKOWSKI J, Floege J, Fliser D, Bohm M, et al
    Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options.
    Circulation. 2021;143:1157-1172.
    PubMed     Abstract available


  208. GREEN JB
    Cardiovascular Consequences of Gestational Diabetes.
    Circulation. 2021;143:988-990.
    PubMed    


  209. PELLEGRINI D, Kawakami R, Guagliumi G, Sakamoto A, et al
    Microthrombi as a Major Cause of Cardiac Injury in COVID-19: A Pathologic Study.
    Circulation. 2021;143:1031-1042.
    PubMed     Abstract available


  210. BOLLI A, Di Domenico P, Pastorino R, Busby GB, et al
    Risk of Coronary Artery Disease Conferred by Low-Density Lipoprotein Cholesterol Depends on Polygenic Background.
    Circulation. 2021 Mar 8. doi: 10.1161/CIRCULATIONAHA.120.051843.
    PubMed    


  211. HENRY TD, Tomey MI, Tamis-Holland JE, Thiele H, et al
    Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Mar 4:CIR0000000000000959. doi: 10.1161/CIR.0000000000000959.
    PubMed     Abstract available


  212. PENG AW, Dardari ZA, Blumenthal RS, Dzaye O, et al
    Very High Coronary Artery Calcium (CAC >/= 1000) and Association with CVD Events, Non-CVD Outcomes, and Mortality: Results from The Multi-Ethnic Study of Atherosclerosis (MESA).
    Circulation. 2021 Mar 2. doi: 10.1161/CIRCULATIONAHA.120.050545.
    PubMed     Abstract available


  213. CHUZI S, Kuang F, Khan SS
    Hidden in Plain Sight: An Elusive Cause of Cardiogenic Shock.
    Circulation. 2021;143:959-964.
    PubMed    


    February 2021
  214. PUTOT A, Cottin Y, Zeller M
    Letter by Putot et al Regarding Article, "Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction".
    Circulation. 2021;143:e250-e251.
    PubMed    


  215. HORIUCHI Y, Wettersten N, Maisel A
    Response by Horiuchi et al to Letter Regarding Article, "Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction".
    Circulation. 2021;143:e252-e253.
    PubMed    



  216. Correction to: Risk of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-1RA Therapy.
    Circulation. 2021;143:e744.
    PubMed    


  217. GOFF DC JR, Khan SS, Lloyd-Jones D, Arnett DK, et al
    Bending the Curve in Cardiovascular Disease Mortality: Bethesda + 40 and Beyond.
    Circulation. 2021;143:837-851.
    PubMed     Abstract available


  218. FORTE E, Perkins B, Sintou A, Kalkat HS, et al
    Cross-Priming Dendritic Cells Exacerbate Immunopathology After Ischemic Tissue Damage in the Heart.
    Circulation. 2021;143:821-836.
    PubMed     Abstract available


  219. YONG CM, Balasubramanian S, Douglas PS, Agarwal P, et al
    Temporal Trends in the Proportion of Women Physician Speakers at Major Cardiovascular Conferences.
    Circulation. 2021;143:755-757.
    PubMed    


  220. ELHARRAM M, Hillier E, Hawkins S, Mikami Y, et al
    Regional Heterogeneity in the Coronary Vascular Response in Women With Chest Pain and Nonobstructive Coronary Artery Disease.
    Circulation. 2021;143:764-766.
    PubMed    


  221. JI H, Niiranen TJ, Rader F, Henglin M, et al
    Sex Differences in Blood Pressure Associations With Cardiovascular Outcomes.
    Circulation. 2021;143:761-763.
    PubMed    


  222. FERRACANE E, Bartoli L, Messori A
    Letter by Ferracane et al Regarding Article, "Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials".
    Circulation. 2021;143:e232-e233.
    PubMed    


  223. KESSLER T, Cassese S, Kastrati A
    Letter by Kessler et al Regarding Article, "Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials".
    Circulation. 2021;143:e230-e231.
    PubMed    


  224. NAVARESE EP, Khan SU, James S
    Response by Navarese et al to Letters Regarding Article, "Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials".
    Circulation. 2021;143:e236-e237.
    PubMed    


  225. ANGIOLILLO DJ, Bhatt DL, Cannon CP, Eikelboom JW, et al
    Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update.
    Circulation. 2021;143:583-596.
    PubMed     Abstract available


  226. ALKHALIL M, Kuzemczak M
    Letter by Alkhalil and Kuzemczak Regarding Article, "Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials".
    Circulation. 2021;143:e234-e235.
    PubMed    


  227. KARABINOS I, Kostaki P, Panagopoulos Z
    Bizarre Downsloping ST Segment Elevation Challenge.
    Circulation. 2021;143:599-601.
    PubMed    


  228. YBARRA LF, Rinfret S, Brilakis ES, Karmpaliotis D, et al
    Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations.
    Circulation. 2021;143:479-500.
    PubMed     Abstract available


  229. GUNDERSON EP, Sun B, Catov JM, Carnethon M, et al
    Gestational Diabetes History and Glucose Tolerance After Pregnancy Associated With Coronary Artery Calcium in Women During Midlife: The CARDIA Study.
    Circulation. 2021 Feb 1. doi: 10.1161/CIRCULATIONAHA.120.047320.
    PubMed    


    January 2021
  230. BRAUER M, Casadei B, Harrington RA, Kovacs R, et al
    Taking a Stand Against Air Pollution-The Impact on Cardiovascular Disease: A Joint Opinion From the World Heart Federation, American College of Cardiology, American Heart Association, and the European Society of Cardiology.
    Circulation. 2021 Jan 28:CIRCULATIONAHA120052666.
    PubMed     Abstract available


  231. TOMCSANYI J, Paulik R, Fresz T
    Acute Coronary Syndrome With Tall R Waves and Inverted T Waves in the Precordial Leads: An Ignored Entity.
    Circulation. 2021;143:397-400.
    PubMed    


  232. OLLITRAULT P, Dolladille C, Chretien B, Milliez P, et al
    Cardiovascular Toxicities Associated With Loperamide: Analysis of the World Health Organization Pharmacovigilance Database.
    Circulation. 2021;143:403-405.
    PubMed    


  233. SNIDER JC, Riley LA, Mallory NT, Bersi MR, et al
    Targeting 5-HT2B Receptor Signaling Prevents Border Zone Expansion and Improves Microstructural Remodeling after Myocardial Infarction.
    Circulation. 2021 Jan 21. doi: 10.1161/CIRCULATIONAHA.120.051517.
    PubMed     Abstract available


  234. MCEVOY JW
    Letter by McEvoy Regarding Article, "Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults".
    Circulation. 2021;143:e20-e21.
    PubMed    


  235. LEE H, Yano Y, Cho SMJ, Lloyd-Jones DM, et al
    Response by Lee et al to Letter Regarding Article, "Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults".
    Circulation. 2021;143:e22-e23.
    PubMed    


  236. HIJAZI Z, Alexander JH, Li Z, Wojdyla DM, et al
    Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients with Atrial Fibrillation After Acute Coronary Syndrome or PCI: Insights from The AUGUSTUS Trial.
    Circulation. 2021 Jan 19. doi: 10.1161/CIRCULATIONAHA.120.051020.
    PubMed     Abstract available


  237. BOIS MC, Boire NA, Layman AJ, Aubry MC, et al
    COVID-19-Associated Nonocclusive Fibrin Microthrombi in the Heart.
    Circulation. 2021;143:230-243.
    PubMed     Abstract available


  238. SCHWARTZ GG, Steg PG, Bhatt DL, Bittner VA, et al
    Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial.
    Circulation. 2021 Jan 13. doi: 10.1161/CIRCULATIONAHA.120.049447.
    PubMed     Abstract available


  239. YOUNG JM, Sage JN, Pickering JW, Bannister L, et al
    Next-Day Troponin Tests in Real-World Implementation of Baseline Troponin Rule-Out of Myocardial Infarction Demonstrates Minimal Delayed Troponin Rises.
    Circulation. 2021;143:202-204.
    PubMed    


  240. O'FEE K, Panza JA, Brown DL
    Association of Inducible Myocardial Ischemia With Long-Term Mortality and Benefit From Coronary Artery Bypass Graft Surgery in Ischemic Cardiomyopathy: Ten-Year Follow-Up of the STICH Trial.
    Circulation. 2021;143:205-207.
    PubMed    


  241. BHASIN D, Isser HS, Gupta A
    Chest Pain With ST-Segment Elevation in a Young Woman: A Broken Heart?
    Circulation. 2021;143:197-201.
    PubMed    


  242. KUEHN BM
    Pandemic Throws Cardiovascular Trials Off Course.
    Circulation. 2021;143:89-90.
    PubMed    


  243. RASANEN M, Sultan I, Paech J, Hemanthakumar KA, et al
    VEGF-B Promotes Endocardium-Derived Coronary Vessel Development and Cardiac Regeneration.
    Circulation. 2021;143:65-77.
    PubMed     Abstract available


  244. QI Z, Hu L, Zhang J, Yang W, et al
    PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36.
    Circulation. 2021;143:45-61.
    PubMed     Abstract available


    December 2020
  245. IGLESIAS JF, Valgimigli M, Carbone F, Lauriers N, et al
    Effects of Fentanyl Versus Morphine on Ticagrelor-Induced Platelet Inhibition in Patients With ST-Segment Elevation Myocardial Infarction: The PERSEUS Randomized Trial.
    Circulation. 2020;142:2479-2481.
    PubMed    



  246. Correction to: Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study.
    Circulation. 2020;142:e632.
    PubMed    


  247. PAL N, Padala S, Klein K
    Letter by Pal et al Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
    Circulation. 2020;142:e501-e502.
    PubMed    


  248. BELLEY-COTE EP, Whitlock RP
    Letter by Belley-Cote and Whitlock Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
    Circulation. 2020;142:e503.
    PubMed    


  249. MAHMOOD E, Sharkey A, Matyal R, Mahmood F, et al
    Response by Mahmood et al to Letter Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
    Circulation. 2020;142:e504-e505.
    PubMed    


  250. VLACHOJANNIS GJ, Wilschut JM, Vogel RF, Lemmert ME, et al
    Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment-Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial.
    Circulation. 2020;142:2316-2328.
    PubMed     Abstract available


  251. DAVE CV, Kim SC, Goldfine AB, Glynn RJ, et al
    Risk of Cardiovascular Outcomes in Type 2 Diabetes Patients Following Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-IRA Therapy.
    Circulation. 2020 Dec 11. doi: 10.1161/CIRCULATIONAHA.120.047965.
    PubMed     Abstract available


  252. SOGAARD M, Nielsen PB, Skjoth F, Eldrup N, et al
    Temporal Changes in Secondary Prevention and Cardiovascular Outcomes after Revascularization for Peripheral Arterial Disease in Denmark: A Nationwide Cohort Study.
    Circulation. 2020 Dec 10. doi: 10.1161/CIRCULATIONAHA.120.047994.
    PubMed     Abstract available


  253. ARNADOTTIR A, Pedersen S, Hasselbalch RB, Goetze JP, et al
    Temporal Release of High-Sensitivity Cardiac Troponin T and I and Copeptin After Brief Induced Coronary Artery Balloon Occlusion in Humans.
    Circulation. 2020 Dec 10. doi: 10.1161/CIRCULATIONAHA.120.046574.
    PubMed     Abstract available



  254. Correction to: Guidance to Reduce the Cardiovascular Burden of Ambient Air Pollutants: A Policy Statement From the American Heart Association.
    Circulation. 2020;142:e449.
    PubMed    


  255. MELHEM NJ, Chajadine M, Gomez I, Howangyin KY, et al
    Endothelial Cell Indoleamine 2, 3-Dioxygenase 1 Alters Cardiac Function Following Myocardial Infarction Through Kynurenine.
    Circulation. 2020 Dec 4. doi: 10.1161/CIRCULATIONAHA.120.050301.
    PubMed     Abstract available


  256. SAFFORD MM, Reshetnyak E, Sterling MR, Richman JS, et al
    Number of Social Determinants of Health and Fatal and Nonfatal Incident Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
    Circulation. 2020 Dec 3. doi: 10.1161/CIRCULATIONAHA.120.048026.
    PubMed     Abstract available


  257. CHAITMAN BR, Alexander KP, Cyr DD, Berger JS, et al
    Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons.
    Circulation. 2020 Dec 3. doi: 10.1161/CIRCULATIONAHA.120.047987.
    PubMed     Abstract available


  258. FORAKER RE, Benziger CP, DeBarmore BM, Cene CW, et al
    Achieving Optimal Population Cardiovascular Health Requires an Interdisciplinary Team and a Learning Healthcare System: A Scientific Statement From the American Heart Association.
    Circulation. 2020 Dec 3:CIR0000000000000913. doi: 10.1161/CIR.0000000000000913.
    PubMed     Abstract available


  259. LIANG T, Gao F, Jiang J, Lu YW, et al
    Loss of Phosphatase and Tensin Homolog Promotes Cardiomyocyte Proliferation and Cardiac Repair After Myocardial Infarction.
    Circulation. 2020;142:2196-2199.
    PubMed    


  260. CAPODANNO D, Angiolillo DJ
    Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus.
    Circulation. 2020;142:2172-2188.
    PubMed     Abstract available


    November 2020
  261. EL KHOUDARY SR, Aggarwal B, Beckie TM, Hodis HN, et al
    Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association.
    Circulation. 2020 Nov 30:CIR0000000000000912. doi: 10.1161/CIR.0000000000000912.
    PubMed     Abstract available


  262. EZEKOWITZ JA, Savu A, Welsh RC, McAlister FA, et al
    Is There a Sex Gap in Surviving an Acute Coronary Syndrome or Subsequent Development of Heart Failure?
    Circulation. 2020 Nov 30. doi: 10.1161/CIRCULATIONAHA.120.048015.
    PubMed    


  263. ARVANITIS M, Qi G, Bhatt DL, Post WS, et al
    A Linear and Non-Linear Mendelian Randomization Analysis of the Association Between Diastolic Blood Pressure and Cardiovascular Events: The J Curve Revisited.
    Circulation. 2020 Nov 30. doi: 10.1161/CIRCULATIONAHA.120.049819.
    PubMed     Abstract available


  264. SCHOEPFER H, Nestelberger T, Boeddinghaus J, Twerenbold R, et al
    Effect of a Proposed Modification of the Type 1 and Type 2 Myocardial Infarction Definition on Incidence and Prognosis.
    Circulation. 2020;142:2083-2085.
    PubMed    



  265. Correction to: Randomized Pilot Clinical Trial of Early Coronary Angiography Versus No Early Coronary Angiography After Cardiac Arrest Without ST-Segment Elevation: The PEARL Study.
    Circulation. 2020;142:e374.
    PubMed    


  266. LEMKES JS
    Coronary Angiography After Cardiac Arrest: A Deep Dive for PEARL.
    Circulation. 2020;142:2013-2015.
    PubMed    


  267. KIM HS, Kang J, Hwang D, Han JK, et al
    Durable Polymer Versus Biodegradable Polymer Drug-Eluting Stents After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: The HOST-REDUCE-POLYTECH-ACS Trial.
    Circulation. 2020 Nov 18. doi: 10.1161/CIRCULATIONAHA.120.051700.
    PubMed     Abstract available


  268. ROUBILLE F, Tardif JC
    Colchicine for Secondary Cardiovascular Prevention in Coronary Disease.
    Circulation. 2020;142:1901-1904.
    PubMed    


  269. SCIRICA BM, Cannon CP, Fisher NDL, Gaziano TA, et al
    Digital Care Transformation: Interim Report From the First 5000 Patients Enrolled in a Remote Algorithm-Based Cardiovascular Risk Management Program to Improve Lipid and Hypertension Control.
    Circulation. 2020 Nov 17. doi: 10.1161/CIRCULATIONAHA.120.051913.
    PubMed    


  270. RODRIGUEZ F, Solomon N, de Lemos JA, Das SR, et al
    Racial and Ethnic Differences in Presentation and Outcomes for Patients Hospitalized with COVID-19: Findings from the American Heart Association's COVID-19 Cardiovascular Disease Registry.
    Circulation. 2020 Nov 17. doi: 10.1161/CIRCULATIONAHA.120.052278.
    PubMed     Abstract available


  271. HENDREN NS, de Lemos JA, Ayers C, Das SR, et al
    Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry.
    Circulation. 2020 Nov 17. doi: 10.1161/CIRCULATIONAHA.120.051936.
    PubMed    


  272. PACKARD CJ
    Letter by Packard Regarding Article, "Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Tr
    Circulation. 2020;142:e333-e334.
    PubMed    


  273. WRIGHT AK, Suarez-Ortegon MF, Read SH, Kontopantelis E, et al
    Risk Factor Control and Cardiovascular Event Risk in People With Type 2 Diabetes in Primary and Secondary Prevention Settings.
    Circulation. 2020;142:1925-1936.
    PubMed     Abstract available


  274. SCHWARTZ GG, Szarek M, Bittner VA, Steg PG, et al
    Response by Schwartz et al to Letter Regarding Article, "Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Ran
    Circulation. 2020;142:e335-e336.
    PubMed    


  275. FILIPPATOS G, Anker SD, Agarwal R, Pitt B, et al
    Finerenone and Cardiovascular Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes.
    Circulation. 2020 Nov 16. doi: 10.1161/CIRCULATIONAHA.120.051898.
    PubMed     Abstract available


  276. KALSTAD AA, Myhre PL, Laake K, Tveit SH, et al
    Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction: A Randomized Controlled Trial.
    Circulation. 2020 Nov 15. doi: 10.1161/CIRCULATIONAHA.120.052209.
    PubMed     Abstract available


  277. REYNOLDS HR, Maehara A, Kwong RY, Sedlak T, et al
    Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of MINOCA in Women.
    Circulation. 2020 Nov 14. doi: 10.1161/CIRCULATIONAHA.120.052008.
    PubMed     Abstract available


  278. CHERNEY DZI, McGuire DK, Charbonnel B, Cosentino F, et al
    Gradient of Risk and Associations with Cardiovascular Efficacy of Ertugliflozin by Measures of Kidney Function: Observations from VERTIS CV.
    Circulation. 2020 Nov 13. doi: 10.1161/CIRCULATIONAHA.120.051901.
    PubMed    


  279. MCMURRAY JJV, Wheeler DC, Stefansson BV, Jongs N, et al
    Effect of Dapagliflozin on Clinical Outcomes in Patients with Chronic Kidney Disease, With and Without Cardiovascular Disease.
    Circulation. 2020 Nov 13. doi: 10.1161/CIRCULATIONAHA.120.051675.
    PubMed     Abstract available


  280. SIMON JN, Vrellaku B, Monterisi S, Chu SM, et al
    Oxidation of Protein Kinase A Regulatory Subunit PKARIalpha Protects Against Myocardial Ischemia-Reperfusion Injury by Inhibiting Lysosomal-Triggered Calcium Release.
    Circulation. 2020 Nov 13. doi: 10.1161/CIRCULATIONAHA.120.046761.
    PubMed     Abstract available


  281. ANKER SD, Butler J, Filippatos G, Khan MS, et al
    Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial.
    Circulation. 2020 Nov 11. doi: 10.1161/CIRCULATIONAHA.120.051824.
    PubMed     Abstract available


  282. ALEXANDER JH, Smith PK
    Are We At Risk of Depriving Patients Lifesaving Cardiac Surgery?: Implications of the ISCHEMIA Trial for Coronary Artery Bypass Graft Surgery.
    Circulation. 2020;142:1797-1798.
    PubMed    


  283. ALBERT CL, Carmona-Rubio AE, Weiss AJ, Procop GG, et al
    The Enemy Within: Sudden-Onset Reversible Cardiogenic Shock With Biopsy-Proven Cardiac Myocyte Infection by Severe Acute Respiratory Syndrome Coronavirus 2.
    Circulation. 2020;142:1865-1870.
    PubMed    


  284. PATEL KV, Bahnson JL, Gaussoin SA, Johnson KC, et al
    Association of Baseline and Longitudinal Changes in Body Composition Measures With Risk of Heart Failure and Myocardial Infarction in Type 2 Diabetes: Findings From the Look AHEAD Trial.
    Circulation. 2020 Nov 9. doi: 10.1161/CIRCULATIONAHA.120.050941.
    PubMed    


  285. VALVERDE I, Singh Y, Sanchez-de-Toledo J, Theocharis P, et al
    Acute Cardiovascular Manifestations in 286 Children with Multisystem Inflammatory Syndrome Associated with COVID-19 Infection in Europe.
    Circulation. 2020 Nov 9. doi: 10.1161/CIRCULATIONAHA.120.050065.
    PubMed     Abstract available


  286. HONIGBERG MC, Zekavat SM, Niroula A, Griffin GK, et al
    Premature Menopause, Clonal Hematopoiesis, and Coronary Artery Disease in Postmenopausal Women.
    Circulation. 2020 Nov 9. doi: 10.1161/CIRCULATIONAHA.120.051775.
    PubMed     Abstract available


  287. KAUFMAN JD, Elkind MSV, Bhatnagar A, Koehler K, et al
    Guidance to Reduce the Cardiovascular Burden of Ambient Air Pollutants: A Policy Statement From the American Heart Association.
    Circulation. 2020 Nov 5:CIR0000000000000930. doi: 10.1161/CIR.0000000000000930.
    PubMed     Abstract available



  288. Correction to: Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination with Loop Diuretics in Patients with Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF Trial.
    Circulation. 2020;142:e316.
    PubMed    


  289. KARIO K, Hoshide S, Mizuno H, Kabutoya T, et al
    Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study.
    Circulation. 2020 Nov 2. doi: 10.1161/CIRCULATIONAHA.120.049730.
    PubMed    


    October 2020
  290. AYTEKIN A, Ndrepepa G, Neumann FJ, Menichelli M, et al
    Ticagrelor or Prasugrel in Patients with ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Circulation. 2020 Oct 29. doi: 10.1161/CIRCULATIONAHA.120.050244.
    PubMed     Abstract available


  291. LOWENSTEIN CJ, Solomon SD
    Severe COVID-19 Is a Microvascular Disease.
    Circulation. 2020;142:1609-1611.
    PubMed    


  292. NASLUND E, Stenberg E, Hofmann R, Ottosson J, et al
    Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Previous Myocardial Infarction and Severe Obesity: A Nationwide Cohort Study.
    Circulation. 2020 Oct 26. doi: 10.1161/CIRCULATIONAHA.120.048585.
    PubMed    


  293. WILLIAMS MC, Newby DE, Dey D, Dweck MR, et al
    Response by Williams et al to Letter Regarding Article, "Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the
    Circulation. 2020;142:e244-e245.
    PubMed    


  294. ALFONSO F, Cecconi A, Jimenez-Borreguero J
    Letter by Alfonso et al Regarding Article, "Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the Heart)".
    Circulation. 2020;142:e242-e243.
    PubMed    


  295. SIONTIS GCM, Raber L
    Letter by Siontis and Raber Regarding Article, "Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART)".
    Circulation. 2020;142:e240-e241.
    PubMed    


  296. NOLAN JP, Maconochie I, Soar J, Olasveengen TM, et al
    Executive Summary: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2020;142.
    PubMed    


  297. MORLEY PT, Atkins DL, Finn JC, Maconochie I, et al
    Evidence Evaluation Process and Management of Potential Conflicts of Interest: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2020;142.
    PubMed    


  298. GREIF R, Bhanji F, Bigham BL, Bray J, et al
    Education, Implementation, and Teams: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2020;142.
    PubMed     Abstract available


  299. MACONOCHIE IK, Aickin R, Hazinski MF, Atkins DL, et al
    Pediatric Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2020;142.
    PubMed     Abstract available


  300. WYCKOFF MH, Wyllie J, Aziz K, de Almeida MF, et al
    Neonatal Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2020;142.
    PubMed     Abstract available


  301. OLASVEENGEN TM, Mancini ME, Perkins GD, Avis S, et al
    Adult Basic Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2020;142.
    PubMed     Abstract available


  302. BERG KM, Soar J, Andersen LW, Bottiger BW, et al
    Adult Advanced Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2020;142.
    PubMed     Abstract available


  303. MERCHANT RM, Topjian AA, Panchal AR, Cheng A, et al
    Part 1: Executive Summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2020;142.
    PubMed    


  304. PANCHAL AR, Bartos JA, Cabanas JG, Donnino MW, et al
    Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2020;142.
    PubMed    


  305. AZIZ K, Lee HC, Escobedo MB, Hoover AV, et al
    Part 5: Neonatal Resuscitation: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2020;142.
    PubMed    


  306. CHENG A, Magid DJ, Auerbach M, Bhanji F, et al
    Part 6: Resuscitation Education Science: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2020;142.
    PubMed    


  307. TOPJIAN AA, Raymond TT, Atkins D, Chan M, et al
    Part 4: Pediatric Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2020;142.
    PubMed    


  308. MAGID DJ, Aziz K, Cheng A, Hazinski MF, et al
    Part 2: Evidence Evaluation and Guidelines Development: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2020;142.
    PubMed     Abstract available


  309. BERG KM, Cheng A, Panchal AR, Topjian AA, et al
    Part 7: Systems of Care: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2020;142.
    PubMed     Abstract available


  310. MURTHY VL, Reis JP, Pico AR, Kitchen R, et al
    Comprehensive Metabolic Phenotyping Refines Cardiovascular Risk in Young Adults.
    Circulation. 2020 Oct 19. doi: 10.1161/CIRCULATIONAHA.120.047689.
    PubMed     Abstract available


  311. SHAH P, deFilippi CR, Mullins KE
    Navigating COVID-19 Testing, Special Considerations for the Cardiovascular Clinician.
    Circulation. 2020 Oct 16. doi: 10.1161/CIRCULATIONAHA.120.051183.
    PubMed    


  312. MODIN D, Claggett B, Sindet-Pedersen C, Lassen MCH, et al
    Acute COVID-19 and the Incidence of Ischemic Stroke and Acute Myocardial Infarction.
    Circulation. 2020 Oct 15. doi: 10.1161/CIRCULATIONAHA.120.050809.
    PubMed    


  313. MYHRE PL, Prebensen C, Strand H, Roysland R, et al
    Growth Differentiation Factor-15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized with COVID-19.
    Circulation. 2020 Oct 15. doi: 10.1161/CIRCULATIONAHA.120.050360.
    PubMed     Abstract available



  314. Correction to: Prioritizing Candidates of Post-Myocardial Infarction Heart Failure Using Plasma Proteomics and Single-Cell Transcriptomics.
    Circulation. 2020;142:e234.
    PubMed    



  315. Correction to: Initial Invasive versus Conservative Management of Stable Ischemic Heart Disease Patients with a History of Heart Failure or Left Ventricular Dysfunction: Insights from the ISCHEMIA Trial.
    Circulation. 2020;142:e236.
    PubMed    



  316. Correction to: Targeted Cardiac Overexpression of A20 Improves Left Ventricular Performance and Reduces Compensatory Hypertrophy After Myocardial Infarction.
    Circulation. 2020;142:e238.
    PubMed    


  317. WANG TJ
    The Evolution of the Cardiovascular Biomarker Study.
    Circulation. 2020;142:1422-1424.
    PubMed    


  318. FRANCHI F, Rollini F, Been L, Briceno M, et al
    Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention
    Circulation. 2020;142:1500-1502.
    PubMed    


  319. MSZAR R, Nasir K, Santos RD
    Coronary Artery Calcification in Familial Hypercholesterolemia: An Opportunity for Risk Assessment and Shared Decision Making With the Power of Zero?
    Circulation. 2020;142:1405-1407.
    PubMed    


  320. CACERES BA, Streed CG Jr, Corliss HL, Lloyd-Jones DM, et al
    Assessing and Addressing Cardiovascular Health in LGBTQ Adults: A Scientific Statement From the American Heart Association.
    Circulation. 2020 Oct 8:CIR0000000000000914. doi: 10.1161/CIR.0000000000000914.
    PubMed     Abstract available


  321. COSENTINO F, Cannon CP, Cherney DZI, Masiukiewicz U, et al
    Efficacy of Ertugliflozin on Heart Failure-Related Events in Patients with Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease: Results of the VERTIS CV Trial.
    Circulation. 2020 Oct 7. doi: 10.1161/CIRCULATIONAHA.120.050255.
    PubMed     Abstract available


  322. BENEDETTO U, Gaudino MF, Dimagli A, Gerry S, et al
    Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery.
    Circulation. 2020;142:1320-1329.
    PubMed     Abstract available


  323. DUNN AN, Donnellan E, Johnston DR, Alashi A, et al
    Long-Term Outcomes of Patients With Mediastinal Radiation-Associated Coronary Artery Disease Undergoing Coronary Revascularization With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting.
    Circulation. 2020;142:1399-1401.
    PubMed    


  324. RUEL M, Gardner T, Fischbein M, de Lemos J, et al
    Introduction to the 2020 Circulation Cardiovascular Surgery-Themed Issue.
    Circulation. 2020;142:1313-1314.
    PubMed    


  325. LYTLE B, Gaudino M
    Fractional Flow Reserve for Coronary Artery Bypass Surgery.
    Circulation. 2020;142:1315-1316.
    PubMed    


  326. OHBE H, Goto T, Miyamoto Y, Yasunaga H, et al
    Risk of Cardiovascular Events After Spouse's ICU Admission.
    Circulation. 2020 Oct 5. doi: 10.1161/CIRCULATIONAHA.120.047873.
    PubMed    


  327. DROBNI ZD, Alvi RM, Taron J, Zafar A, et al
    Association Between Immune Checkpoint Inhibitors with Cardiovascular Events and Atherosclerotic Plaque.
    Circulation. 2020 Oct 2. doi: 10.1161/CIRCULATIONAHA.120.049981.
    PubMed     Abstract available


    September 2020
  328. ZUREK M, Johansson E, Palmer M, Albery T, et al
    Neuregulin-1 Induces Cardiac Hypertrophy and Impairs Cardiac Performance in Post-Myocardial Infarction Rats.
    Circulation. 2020;142:1308-1311.
    PubMed    


  329. XIA N, Lu Y, Gu M, Li N, et al
    A Unique Population of Regulatory T Cells in Heart Potentiates Cardiac Protection from Myocardial Infarction.
    Circulation. 2020 Sep 28. doi: 10.1161/CIRCULATIONAHA.120.046789.
    PubMed     Abstract available


  330. KERN KB, Radsel P, Jentzer JC, Seder DB, et al
    A Randomized Pilot Clinical Trial of Early Coronary Angiography Versus No Early Coronary Angiography for Post-Cardiac Arrest Patients Without ST-Segment Elevation: The PEARL Study.
    Circulation. 2020 Sep 28. doi: 10.1161/CIRCULATIONAHA.120.049569.
    PubMed     Abstract available


  331. RUIZ-VILLALBA A, Romero JP, Hernandez SC, Vilas-Zornoza A, et al
    Single-Cell RNA-seq Analysis Reveals a Crucial Role for Collagen Triple Helix Repeat Containing 1 (CTHRC1) Cardiac Fibroblasts after Myocardial Infarction.
    Circulation. 2020 Sep 25. doi: 10.1161/CIRCULATIONAHA.119.044557.
    PubMed     Abstract available


  332. MALESZEWSKI JJ, Young PM, Ackerman MJ, Halushka MK, et al
    An Urgent Need for Studies of the Late Effects of SARS-CoV-2 on the Cardiovascular System.
    Circulation. 2020 Sep 24. doi: 10.1161/CIRCULATIONAHA.120.051362.
    PubMed    


  333. CUSHMAN M, Shay CM, Howard VJ, Jimenez MC, et al
    Ten-Year Differences in Women's Awareness Related to Coronary Heart Disease: Results of the 2019 American Heart Association National Survey: A Special Report From the American Heart Association.
    Circulation. 2020 Sep 21:CIR0000000000000907. doi: 10.1161/CIR.0000000000000907.
    PubMed     Abstract available


  334. PETERS SAE, Colantonio LD, Dai Y, Zhao H, et al
    Trends in Recurrent Coronary Heart Disease Following Myocardial Infarction Among US Women and Men Between 2008 and 2017.
    Circulation. 2020 Sep 21. doi: 10.1161/CIRCULATIONAHA.120.047065.
    PubMed     Abstract available


  335. KLASSEN SL, Kwan GF, Bukhman G
    The COVID-19 pandemic: a massive threat for those living with cardiovascular disease among the poorest billion.
    Circulation. 2020 Sep 18. doi: 10.1161/CIRCULATIONAHA.120.047969.
    PubMed    


    August 2020
  336. LOPES RD, Alexander KP, Stevens SR, Reynolds HR, et al
    Initial Invasive versus Conservative Management of Stable Ischemic Heart Disease Patients with a History of Heart Failure or Left Ventricular Dysfunction: Insights from the ISCHEMIA Trial.
    Circulation. 2020 Aug 29. doi: 10.1161/CIRCULATIONAHA.120.050304.
    PubMed     Abstract available


  337. GAN L, Xie D, Lau WB, Ma XL, et al
    Response by Gan et al to Letter Regarding Article, "Small Extracellular Microvesicles Mediated Pathological Communications Between Dysfunctional Adipocytes and Cardiomyocytes as a Novel Mechanism Exacerbating Ischemia/Reperfusion Injury in Diabetic Mi
    Circulation. 2020;142:e99-e100.
    PubMed    


  338. REN C, Chen H, Xie Y
    Letter by Ren et al Regarding Article, "Small Extracellular Microvesicles Mediated Pathological Communications Between Dysfunctional Adipocytes and Cardiomyocytes as a Novel Mechanism Exacerbating Ischemia/Reperfusion Injury in Diabetic Mice".
    Circulation. 2020;142:e97-e98.
    PubMed    


  339. LI Y, Ding F, Shen Z
    Letter by Li et al Regarding Article, "Small Extracellular Microvesicles Mediated Pathological Communications Between Dysfunctional Adipocytes and Cardiomyocytes as a Novel Mechanism Exacerbating Ischemia/Reperfusion Injury in Diabetic Mice".
    Circulation. 2020;142:e95-e96.
    PubMed    



  340. Correction to: Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial.
    Circulation. 2020;142:e71.
    PubMed    


    June 2020
  341. SELVARAJ S, Kelly DP, Margulies KB
    Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure.
    Circulation. 2020;141:1800-1812.
    PubMed     Abstract available


    April 2020
  342. LI L, Li H, Tien CL, Jain MK, et al
    Kruppel-Like Factor 15 Regulates the Circadian Susceptibility to Ischemia Reperfusion Injury in the Heart.
    Circulation. 2020;141:1427-1429.
    PubMed    


  343. BETHEL MA, Stevens SR, Buse JB, Choi J, et al
    Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes.
    Circulation. 2020;141:1360-1370.
    PubMed     Abstract available


  344. KNOTT KD, Seraphim A, Augusto JB, Xue H, et al
    The Prognostic Significance of Quantitative Myocardial Perfusion: An Artificial Intelligence-Based Approach Using Perfusion Mapping.
    Circulation. 2020;141:1282-1291.
    PubMed     Abstract available


  345. JIANG M, Knight BP, Verma N
    Conduction Abnormalities and Ischemic Cardiomyopathy in an 84-Year-Old Man.
    Circulation. 2020;141:1268-1270.
    PubMed    


  346. CARNETHON MR, Khan SS
    A Feast of Observations About Diet.
    Circulation. 2020;141:1138-1140.
    PubMed    


  347. SAXENA A, Garan AR, Kapur NK, O'Neill WW, et al
    Value of Hemodynamic Monitoring in Patients With Cardiogenic Shock Undergoing Mechanical Circulatory Support.
    Circulation. 2020;141:1184-1197.
    PubMed     Abstract available


    March 2020
  348. SORRENTINO S, Claessen BE, Chandiramani R, Guedeney P, et al
    Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
    Circulation. 2020;141:891-901.
    PubMed     Abstract available


    February 2020
  349. KAZMIRCZAK F, Martin CM, Shenoy C
    Left Ventricular Noncompaction and Cardiogenic Shock.
    Circulation. 2020;141:696-701.
    PubMed    


    January 2020
  350. GAN L, Xie D, Liu J, Lau WB, et al
    Small Extracellular Microvesicles Mediated Pathological Communications between Dysfunctional Adipocytes and Cardiomyocytes as a Novel Mechanisms Exacerbating Ischemia/Reperfusion Injury in Diabetic Mice.
    Circulation. 2020 Jan 10. doi: 10.1161/CIRCULATIONAHA.119.042640.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: